AVAT

Covid-19 development round-up: September 2, 2021

The state of the fight: 

The U.S. FDA set a September date to discuss Pfizer/BioNTech boosters while E.U. officials saw “no urgent need” for boosters in the already vaccinated.
  Recruitment started in India for a late-stage trial of Serum Institute of India’s Covovax in children, and Biological E won approval to study its Corbevax in children.
  Prehospital antiplatelet therapy (such as aspirin) was associated with significantly lower in-hospital mortality in some…
Mentions:
Covid-19, vaccines, drugs, BBIL, Bharat Biotech, Moderna, Pfizer, BioNTech, Sinovac, CNBG, Sinopharm, Walvax, CanSino, CDC, FDA, Nanogen, J&J, Biological E, SII, SK Bioscience, GSK, AstraZeneca, AVAT, COVAX, UNICEF, Lilly, Regeneron, Roche
Read more
Covid-19 development round-up: August 27, 2021

The state of the fight: 

Pfizer/BioNTech’s Comirnaty became the first Covid-19 vaccine to earn full U.S. FDA approval.
  China authorized booster doses for those at high risk of contracting Covid-19.
  Brazil’s Eurofarma Laboratórios will produce Pfizer/BioNTech’s vaccine for exclusive distribution in Latin America.

 

Approved or authorized vaccines

 
British study sees waning protection from shots: The app-based ZOE COVID study (led by a Kings College…

Mentions:
Covid-19, vaccines, drugs, Pfizer, BioNTech, AstraZeneca, Gamaleya Institute, Sinovac, Novavax, SII, Moderna, CNBG, Valneva, FDA, J&J, Inovio, BioCubaFarma, CureVac, COVAX, AVAT
Read more
Covid-19 development round-up: August 6, 2021

The state of the fight: 

Multiple wealthy countries outlined imminent booster dose plans, spurning a WHO plea for patience.
  Novavax pushed back its timeline for seeking U.S. FDA authorization for its vaccine and said the U.S. had paused funding for the shot’s production.
  The African Vaccine Acquisition Trust announced its first shipments of doses.

 

Approved or authorized vaccines

 
J&J’s shot offers up to 96.2% protection against death,…

Mentions:
Covid-19, vaccines, drugs, J&J, AstraZeneca, Pfizer, BioNTech, Moderna, Novavax, FDA, SII, EMA, CNBG, Sinopharm, BBIL, WHO, CDC, Sinovac, Gamaleya Institute, Emergent, AVAT, ACT Accelerator, UNICEF, COVAX, Regeneron, Gilead, GSK, Vir, Lilly
Read more
Covid-19 development round-up: April 1, 2021

The state of the hunt:

Pfizer and BioNTech plan to seek authorization of their vaccine for adolescents age 12-15 after promising Phase 3 results.
  J&J agreed to supply up to 400 million doses of Janssen’s jab to the African Union.
  Serum Institute of India launched clinical trials of its version of the Novavax vaccine candidate.

 

Vaccines


Approved or authorized vaccines
   
New data show lower efficacy for Pfizer/BioNTech: The…

Mentions:
Covid-19, vaccines, drugs, Pfizer, BioNTech, FDA, AstraZeneca, EMA, WHO, Oxford University, CDC, Moderna, NIH, SII, Novavax, CNBG, Sinopharm, Sinovac, J&J, Janssen, BBIL, CanSino, Gritstone Oncology, Iconovo, AVAT, AU, Afreximbank, Emergent, Merck, Ajinomoto Bio-Pharma Services, BIBP, Group 42, RDIF, Gamaleya Institute, TopRidge Pharma, Tibet Rhodiola, Shenzhen Yuanxing Gene-tech, CureVac, Celonic Group, Bio Farma, GSK, CEPI, UNICEF, ACT Accelerator, ACT-A, ACT-A SFF, COVAX AMC, WTO, Africa CDC, MSF, COVAX, Humanigen, Lilly, Vir, Daiichi Sankyo
Read more
Subscribe to AVAT